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Abstract
Background: The low and variable prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae DNA in
human stool contrasts with the paramount role of these methanogenic Archaea in digestion processes. We hypothesized
that this contrast is a consequence of the inefficiencies of current protocols for archaeon DNA extraction. We developed a
new protocol for the extraction and PCR-based detection of M. smithii and M. stadtmanae DNA in human stool.
Methodology/Principal Findings: Stool specimens collected from 700 individuals were filtered, mechanically lysed twice,
and incubated overnight with proteinase K prior to DNA extraction using a commercial DNA extraction kit. Total DNA was
used as a template for quantitative real-time PCR targeting M. smithii and M. stadtmanae 16S rRNA and rpoB genes.
Amplification of 16S rRNA and rpoB yielded positive detection of M. smithii in 95.7% and M. stadtmanae in 29.4% of
specimens. Sequencing of 16S rRNA gene PCR products from 30 randomly selected specimens (15 for M. smithii and 15 for
M. stadtmanae) yielded a sequence similarity of 99–100% using the reference M. smithii ATCC 35061 and M. stadtmanae
DSM 3091 sequences.
Conclusions/Significance: In contrast to previous reports, these data indicate a high prevalence of the methanogens M.
smithii and M. stadtmanae in the human gut, with the former being an almost ubiquitous inhabitant of the intestinal
microbiome.
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Introduction
Archaea are environmental organisms that are associated with the
mucosa in mammals [1–6]. In humans, Archaea are associated with
the vaginal, oral, and intestinal mucosa [1–6]. Because of the
fastidious nature of these strict anaerobes, most current knowledge
about the archaeal flora of mammals is derived from DNA-based
analyses. In the human gut, methanogenic Archaea metabolize
major fermentation products, such as alcohols, short chain organic
acids, carbon dioxide (CO2), and hydrogen (H2) [7]. Until
recently, the diversity of gut methanogens was thought to be
limited to two species: Methanobrevibacter smithii, the most abundant
methanogenic Archaea found in the human gut [1–6,8–10], and
Methanosphaera stadtmanae, which is seldom detected in the human
gut. Both species can be detected by culture and PCR-based assays
targeting the 16S rRNA and mcrA genes [8]. Recently, the DNA of
additional methanogenic Archaea has been detected in human stool
specimens, including DNA sequences that indicate the presence of
a new order of methanogenic Archaea [2,11].
The predominance of M. smithii compared to M. stadtmanae can
be explained by the fact that the genome of the former is more
tailored to the gut environment with regards to metabolic
versatility, genomic evolution ability, and persistence [9]. In the
gut, M. smithii converts H2,C O 2, and formate into CH4 using
carbon as the terminal electron acceptor; this redox reaction
sustains anaerobic respiration, which allows for the production of
ATP [12,13]. This archaeon can also remove fermentation end
products, such as methanol and ethanol, produced by other
bacteria lacking a methanogenic pathway, while M. stadtmanae
energy metabolism is limited to using hydrogen to reduce
methanol to methane and is dependent on acetate as a carbon
source [8]. Methanogenesis is of paramount importance in
preventing the accumulation of gases and other reaction end
products [9]. Accordingly, a metagenomic analysis of the gut flora
in three healthy individuals found that M. smithii comprised up to
11.5% of the gut microorganisms [14]. However, 16S rRNA- and
mcrA gene-based studies detected M. smithii with variable
prevalence in less than half of the tested individuals and no M.
stadtmanae; such results cannot reflect the actual quantity of these
two Archaea in the human gut because of their specific association
with the gut mucosa [14]. We hypothesized that the variable
prevalence of M. smithii DNA in human stool specimens and the
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to limitations in the experimental protocols and to the relatively
small samples comprising three or six individuals [14,15]. We
aimed to establish an optimized protocol for the extraction and
detection of archaeal DNA by exploiting the M. smithii and M.
stadtmanae genome sequences [8,10].
Materials and Methods
2.1. Source of fecal samples
A series of 700 fecal specimens were prospectively collected to
investigate the prevalence of M. smithii and M. stadtmanae. Stool
specimens were stored at 220uC until used. A random subset of 50
specimens was further used to compare the DNA extraction
method developed herein with a reference method. Only one stool
specimen was collected per person, and for each person, sex, age,
and presence of an enteric pathogen in the stool specimen
responsible for diarrhea were documented. This study was
approved by the local Ethics Committee.
2.2. Fecal DNA isolation
Approximately 1 gram of specimen was suspended in 10 ml of
saline buffer and filtered through a Fecal Specimen Filtration Vial
(Orion Diagnostica–Fumouze-Division Diagnostics, Levallois Per-
ret, France). Aliquot of the filtrate (250 ml) was transferred into a
sterile screw-cap Eppendorf tube containing 0.3 g of acid-washed
glass beads (#106 mm, Sigma, Saint-Quentin Fallavier, France)
and shaken to achieve mechanical lysis in a FastPrep BIO 101
apparatus (Qbiogene, Strasbourg, France) at level 6.5 (full speed)
for 90 s. The supernatant was collected and incubated overnight at
56uC with 180 ml of T1 Buffer from the NucleoSpinH Tissue Mini
Kit (Macherey Nagel, Hoerdt, France) and 25 ml of proteinase K
(20 mg/ml). After a second cycle of mechanical lysis as described
above, the filtrate was incubated for 15 min at 100uC. Total DNA
was then extracted using the NucleoSpinH Tissue Mini Kit,
according to the manufacturer’s procedure. Extracted DNA was
eluted with 100 ml of elution buffer and stored at 220uC until
used. A mock extraction performed using 250 ml of sterile water
was used as a negative control for each batch of DNA extractions.
2.3. Real-time quantitative PCR assays
The targeted genes, probes, primer sequences (Eurogentec,
Seraing, Belgium), and PCR product sizes for the four real-time
PCR assays developed in this study are summarized in Table 1.
The sequences of the four probes (Applied Biosystems, Courta-
boeuf, France) and four primer pairs were designed using the M.
smithii ATCC 35061 complete genome (GenBank accession
number CP000678) and the M. stadtmanae DSM 3091 complete
genome sequence (GenBank accession number NC 007681) (both
exhibiting only one copy of the 16S rRNA gene and one copy of
the rpoB gene) via the online Primer 3 program (http://biotools.
umassmed.edu/bioapps/primer3_www.cgi). The specificities of
the PCR primers and probes for the M. smithii ATCC 35061 and
M. stadtmanae DSM 3091 16S rRNA and rpoB genes were verified
in silico using the BLAST program at NCBI (http://www.ncbi.
nlm.nih.gov/BLAST). The specificity was further experimentally
ensured by incorporating the DNA extracted from 43 bacterial
species representative of common gut inhabitants and enteric
pathogens, including M. stadtmanae and M. smithii as positive
controls (Table S2), in the real-time PCR protocol reported below.
The primers and Taqman probes used for total bacterial real-time
qPCR were adapted from the method previously described by
Palmer and collaborators [16]. Real-time PCR assays were
performed with a MX3000
TM system (Stratagene, Amsterdam,
The Netherlands) using the QuantiTect Probe PCR Kit (Qiagen,
Courtaboeuf, France) with 5 pmol of each primer, probe labeled
with FAM or VIC, and 5 ml of DNA (about 2 mg of total DNA) in
a final volume of 25 ml. Positive controls (DNA extracted from M.
smithii DSM861 and M. stadtmanae DSM 3091 strains, German
Collection of Microorganisms and Cell Cultures, Braunschweig,
Germany), an extraction control, no-template controls, and a
quantification scale from 10
27 to 10 target copies were utilized in
each reaction plate. The 16S rRNA and rpoB gene copies were
quantified in a duplex assay, and total bacteria were used in
Table 1. Real-time PCR primers and probes sequences for detecting M. smithii and M. stadtmanae 16S rRNA and rpoB genes and
for detecting all bacteria (Totbact).
Organism Assay Primer/probe name and sequence (59-39) Dye Product size (bp)
M. smithii 16S rRNA Smit.16S-740F, 59-CCGGGTATCTAATCCGGTTC-39 123
Smit.16S-862R, 59-CTCCCAGGGTAGAGGTGAAA-39
Smit.16S FAM, 59-CCGTCAGAATCGTTCCAGTCAG-39 FAM (MGB)
rpoB Ms_rpoBF, 59-AAGGGATTTGCACCCAACAC-39 70
Ms_rpoBR, 59-GACCACAGTTAGGACCCTCTGG-39
Ms_rpoBVIC, 59-ATTTGGTAAGATTTGTCCGAATG-39 VIC (MGB)
M. stadtmanae 16S rRNA Stadt_16SF, 59-AGGAGCGACAGCAGAATGAT-39 97
Stadt_16SR, 59-CAGGACGCTTCACAGTACGA-39
Stadt_16SFAM, 59-TGAGAGGAGGTGCATGGCCG-39 FAM (Taqman)
rpoB stadt_rpoBF, 59-TGCTTGGTATTTGTGCTGGA-39 95
stadt_rpoBR, 59-TCCAAGAGCCTGTTTTGTCA-39
Stadt_rpoBVIC, 59-CACCAAGGAACACAATGGAGGC-39 FAM (Taqman)
All bacteria Totbact Bact 8FM, 59-AGAGTTTGATCMTGGCTCAG-39 327
Bact515R, 59-TTACCGCGGCKGCTGGCAC-39
Bact338K, 59-CCAKACTCCTACGGGAGGCAGCAG-39 VIC (Taqman)
doi:10.1371/journal.pone.0007063.t001
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The PCR amplification program was 95uC for 15 min, followed
by 45 cycles of 95uC for 30 s and 60uC for 1 min. All DNA
samples were tested in duplicate. Results are expressed as the
number of 16S rRNA and rpoB copies per gram of feces. Plasmid
quantification was carried out by inserting a chimeric nucleotide
fragment into the pCR II plasmid (TA cloning Kit Dual Promoter
(pCRII) Invitrogen, Carlsbad, CA, USA), as previously described
[17]. The chimeric fragment contained real-time PCR targets for
M. smithii and M. stadtmanae 16S rRNA and rpoB genes, together
with a universal 16S rRNA bacterial target gene adapted from the
Streptomyces sudanensis strain SD504 sequence (GenBank accession
number EF515876) as an internal control to monitor the absence
of PCR inhibition.
2.4. Sequencing
To sequence the M. smithii and M. stadtmanae DNA in human
feces, real time-PCR products of the 16S rRNA gene were
sequenced for 30 randomly chosen specimens using the primers
Smit.16S-740F, Smit.16S-862R, Stadt_16SF and Stadt_16SR
(Table 1). PCR products were purified and sequenced using the
BigDye Terminator 1.1 Cycle Sequencing kit and the 3130 genetic
analyzer (Applied Biosystems). Negative controls were employed
for each assay. Sequences were analyzed using the Seqscape
program (Applied Biosystems), and similarity values were
determined using the online BLAST program at NCBI.
2.5. Protocol sensitivity
To monitor the sensitivity of our extraction protocol, three stool
specimens presenting low loads of M. smithii 16S rRNA and rpoB
genes supplemented with 100 mlo fM. smithii DSM 861 suspension
were used. For all specimens in both the 16S rRNA and rpoB
assays, the sensitivity was calculated by subtracting the gene copy
number present before addition of M. smithii to that obtained after
and then dividing by the gene copy number obtained for 100 mlo f
a pure suspension of M. smithii. The protocol sensitivity presented
is the average of the three percentages obtained.
2.6. Comparison with the reference DNA extraction
protocol
Total DNA was isolated from 50 stool specimens using the
extraction protocol described above in parallel with the QIAamp
Stool DNA mini kit protocol (Qiagen), as previously reported [14].
The latter kit was used as a gold standard, as a literature review
indicated that this kit was used in almost all recent studies (2005–
2008) dealing with DNA extraction from animal and human
stools. We then compared the numbers of M. smithii 16S rRNA
and rpoB gene copies per gram of stool detected by each DNA
extraction protocol. Numerical data were analyzed using
EPIINFO version 3.4.1 software (Centers for Disease Control
and Prevention, Atlanta, GA). P values were used to assess
statistical significance when comparing the two methods and were
calculated using the non-parametric Kruskal-Wallis test for two
groups. A P value,0.05 was considered to be significant.
Results
3.1. Stool specimens
Stool specimens were collected from 700 persons [408 males
(aged 1 day to 95 years) and 292 females (aged 1 month to 98
years)] (Table S1). The stool specimens of 643 of these patients had
been submitted for the identification of enteric pathogens; the
remaining 57 stool specimens had been submitted for the
determination of Staphylococcus aureus and Salmonella spp. intestinal
carriage in healthy adults without diarrhea and no history of
enteric disease in the past six months. No enteric pathogens were
identified in the healthy adults, whereas enteric pathogens were
cultured from 4 of the remaining 643 patients, including Salmonella
enterica in 2 patients, Staphylococcus aureus in 1 child, and Shigella
sonnei in 1 patient (Table S1).
3.2. Real-time PCR
In-silico analysis using the online BLAST program at NCBI
indicated that the M. smithii and M. stadtmanae real-time PCR
systems were specific for the two species. These data were
experimentally confirmed by the fact that the systems did not
detect the DNA extracted from 43 other enteric organisms in the
presence of positive controls, with the exception of the homologous
methanogenic species. Negative results were obtained for all
negative controls in the assay. Our protocol demonstrated an
extraction efficiency of 89.82% for the 16S rRNA assay and
94.04% for the rpoB assay. In the present study, 670/700 stool
specimens were positive for the M. smithii 16S rRNA or rpoB genes
(95.7%), including 133 specimens that were positive for the 16S
rRNA gene only. The 16S rRNA and the rpoB gene copy numbers
varied from 10.921.45610
11 and from 2.2222.40610
10 copies
per gram of stool, respectively (Table 2). The internal positive
control was detected in 29/29 (100%) stool specimens that
remained negative for M. smithii DNA.
Among these 700 stool specimens, 206 (29.4%) were positive for
M. stadtmanae DNA, including 71 that were positive for the 16S
rRNA gene only. In all cases, M. stadtmanae DNA was detected in
association with M. smithii DNA (Table S1). The 16S rRNA and
the rpoB gene copy numbers varied from 1221.45610
10 and from
37.922.74610
9 copies per gram of stool, respectively (Table 2).
The internal control was detected in 44/44 (100%) randomly
Table 2. Mean, standard deviation, median, and maximal and minimal values of the copy numbers of M. smithii and M.
stadtmanae16S rRNA and rpoB genes per gram of stool in the positive specimens for each assay.
M. smithii M. stadtmanae
16S rRNA assay rpoB assay 16S rRNA assay rpoB assay
Minimum 1,09E+01 2,22E+00 1,20E+01 3,79E+01
Maximum 1,45E+11 2,40E+10 1,45E+10 2,74E+09
Target copy number Mean 2,33E+09 6,46E+08 1,80E+08 6,56E+07
Standard deviation 1,26E+10 2,70E+09 1,25E+09 3,40E+08
Median 4,20E+04 1,72E+04 9,30E+03 2,66E+04
doi:10.1371/journal.pone.0007063.t002
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product.
No statistical correlation was observed between M. smithii/M.
stadtmanae detection or load and the presence of an enteric
pathogen. No statistical difference was detected in M. smithii/M.
stadtmanae detection and load between the 57 healthy individuals
and the individuals who submitted stool samples for pathogen
identification.
3.3. Sequencing
All negative controls lacked PCR products. Direct sequencing of
the 30 16S rRNA gene PCR products yielded a BLAST similarity
of 99% with the reference M. smithii ATCC 35061 16S rRNA gene
sequence (GenBank accession NC_009515) and a BLAST
similarity of 100% with the reference M. stadtmanae DSM 3091
16S rRNA gene sequence (GenBank accession CP000102).
Interestingly, M. smithii DNA was detected in 2 specimens
collected from children aged 1 and 2 years, with estimated
numbers of 10 and 778 M. smithii per gram of stool, respectively. A
sequence similarity of 99% compared to the M. smithii reference
strain was obtained for both children.
3.4. Comparison of DNA extraction protocols
DNA extracted using the QIAamp Stool DNA mini kit was
positive for M. smithii 16S rRNA and rpoB genes in 44/50 (90%)
and 33/50 (66%) specimens, respectively, by quantitative real-time
PCR. DNA extracted using the protocol described herein was
positive for M. smithii 16S rRNA and rpoB genes in 50/50 (100%)
and 49/50 (98%) specimens, respectively. Per 1 g of stool, the
extraction protocol developed herein yielded 100- to 1,000-fold
more gene copies than the reference extraction protocol (P#10
25)
(Table 3).
Discussion
Based on a metagenomic analysis of stool samples collected
from three healthy adults, M. smithii DNA was estimated to
comprise up to 11.5% of the total human gut microbiome [14].
Such a high inoculum is in agreement with the paramount role of
this archaeon in the detoxification of digestion by-products [9], but
contrasts with the relatively low (,50%) rate of detection observed
in studies based on either isolation or PCR-based detection of
specific DNA sequences [5,14,16].
Here, we employed an optimized protocol for the extraction
and specific PCR-based detection of M. smithii and M. stadtmanae
DNA in stool samples and demonstrated that M. smithii DNA can
be detected in the stool of almost all individuals (95.5%) and M.
stadtmanae in 29.4% of individuals. The fact that negative results
were obtained for the negative controls and the fact that all
experiments were conducted under strict rules to prevent
laboratory contamination, together with the recovery of original
sequences, indicate that the positive detection of M. smithii and M.
stadtmanae DNA achieved in this study was not due to specimen
contamination. Moreover, the specificity of the real-time PCR
systems developed herein was ensured by in-silico analysis and
experimental testing using DNA extracted from common human
gut inhabitants and pathogens. A high, 99–100% sequence
similarity of real-time PCR products with that of reference
sequences finally ensured the specificity of the real-time PCR
systems herein reported. Likewise, detection of the internal positive
control in all specimens negative for M. smithii or M. stadtmanae
eliminated the possibility of PCR inhibition. Therefore, the data
likely accurately estimate the prevalence of both M. smithii and M.
stadtmanae in the population studied. Comparison of the DNA
extraction protocol developed herein with the protocol previously
used for metagenomic analysis of the human gut [14,16] revealed
a two to three log difference in the quantity of archaeon DNA,
with greater detection achieved with the new protocol. This
difference in performance was likely due to an optimized
combination of previously reported lysis methods [14,15,18,19].
The fact that members of the family Methanobacteriales, such as M.
smithii and M. stadtmanae, have a proteinase K-resistant cell wall
[20], suggests that double mechanical cell lyses using glass beads
was decisive in the efficiency of DNA extraction. This fact was
further illustrated by the detection of low DNA loads (Tables 2 and
3), whereas the sensitivity was measured to be $10
7 cells per gram
of feces in a previous study [11]. Such a huge difference in the
sensitivity of M. smithii DNA detection may have influenced
previously published data on the prevalence of M. smithii in stool.
This protocol was also shown to be effective for DNA extraction
from Mycobacterium tuberculosis present in stool [21].
In most previous studies, the universal 16S rRNA gene was used
as a suitable target for the molecular detection of archaeal DNA
present in the human and animal gut [14,16,18,22]. The mcrA gene,
which encodes the methyl-coenzyme M reductase in M. smithii, has
also been used [15]. However, M. stadtmanae mcrA gene-derived
primers failed to detect M. stadtmanae in a total of 207 individuals
[11]. We therefore used the rpoB gene, which encodes the b subunit
of RNA polymerase and is one of the core genes shared by Bacteria
and Archaea [23,24]. The rpoB gene has been previously used to infer
phylogenetic relationships between Archaea and was recently
demonstrated to correlate with DNA:DNA hybridization data, as
well as the average nucleotide identity among prokaryotes
[23,25,26]. In the present study, the specificity of M. smithii and
M. stadtmanae detection was confirmed by evaluating two indepen-
dent, universal molecular targets (16S rRNA and rpoB genes) using
specific and highly sensitive quantitative real-time PCR. The latter
gene exhibits a 12% sequence divergence between M. smithii,
conferring a higher specificity than the 16S rRNA gene system.
Moreover, sequencing of the PCR products obtained for M. smithii
Table 3. Copy numbers of M. smithii 16S rRNA and rpoB genes per gram of stool obtained using the protocol reported herein
versus those obtained via the reference Qiagen protocol for M. smithii DNA extraction from human stool (1).
present extraction protocol Qiagen extraction protocol P value
(1)
Assay Mean Standard
Deviation
Median Maximum Minimum Mean Standard
Deviation
Median Maximum Minimum
16S rRNA 4.11e+09 1.23e+10 7.54e+05 7.43e+10 100 3.02e+07 1.25e+08 1.13e+03 7.20e+08 0 #0.00001
rpoB 1.48e+09 3.80e+09 2.94e+06 1.65e+10 0 1.01e+07 4.11e+07 2.20e+03 2.27e+08 0 #0.00001
P values were determined using the non-parametric Kruskal-Wallis test for two groups.
doi:10.1371/journal.pone.0007063.t003
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sequence similarity values were 99% compared to the reference M.
smithii sequence. Likewise, sequence similarity values were 100% for
M. stadtmanae.
Data herein presented shed new light on the biology of
methanogenesis in the human gut. While breath methane
measurement has a high positive predictive value, its sensitivity
was lower than that of real-time molecular detection of
methanogens in healthy individuals, the breath methane test
being positive only for M. smthii inoculum .10
7 organisms per
gram of stool [27]. Indeed, breath methane measurement typically
yields a prevalence of 40% [27,28], in contrast to the 95.7% of
methanogen DNA in our study. Despite the fact that molecular
test, contrary to the breath methane test, detects both alive and
dead methanogens, data herein reported indicate that gut
methanogens are detectable in almost all individuals, regardless
of them being healthy individuals or suffering from intestinal
disease. Morevover, the breath methane test cannot determine the
precise microbial source of methane in the gut; the fact that we
detected M. stadtmanae in addition to M. smithii in about one-third
of individuals, and that other methanogen DNAs have been
detected in some individuals [15,27], suggests that molecular
determination of the gut methanogen flora is essential for any
study dealing with the biology and the dynamics of methanogen-
esis in both healthy individuals and in patients presenting with
intestinal disease under widespread antibiotic and dietary changes.
We did not detect M. smithii and M. stadtmanae in less than 5% of
individuals; whether this lack of detection reflects the limit of
molecular detection or true absence of both methanogens, remains
to be determined. Performing a breath methane test may help
resolve this issue and give a basis to continue molecular detection
of methanogens in such individuals. Our study indicates for the
first time that methane production could be due to at least two
archaeal species in the same individual but the M. smithii and M.
stadtmanae DNA loads were highly variable among specimens. We
did not collect several specimens per individual in a time-
dependent manner, and therefore we cannot ascertain whether
the M. smithii and M. stadtmanae DNA loads remain constant over
time for an individual or vary under physiological and pathological
circumstances. Interestingly, M. smithii DNA was detected in all
stool specimens collected from 16 children younger than 2 years of
age, including one specimen collected from a 2-week-old infant
that was negative using the reference extraction protocol.
Therefore, our results complete previous data demonstrating the
transient detection of M. smithii DNA during the first 5–120 days of
life in stool samples obtained from 7/14 children younger than one
year of age [16]. These data indicate that the acquisition of M.
smithii is an early event in newborns, resulting from maternal or
environmental exposure. M. smithii has been detected in the
vaginal flora, including that of 3/13 pregnant women [2,16].
The DNA extraction protocol and highly specific and sensitive
method of detection and quantification developed in the present
study offer new tools on which to base the optimized, broad-
spectrum molecular detection of Archaea embedded in the complex
microbiomes associated with the mammalian mucosa. This
protocol may aid in identifying additional species of Archaea and
in monitoring modifications in the archaeal flora under various
physiological, pathological, and therapeutic circumstances.
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